CFG
TEVA icon

Citizens Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

Citizens Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-900
Closed -$8K – 895
2019
Q2 		$8K Buy
+900
New +$10.9K ﹤0.01% 600
2019
Q1 		– Sell
-333
Closed -$5K – 785
2018
Q4 		$5K Buy
+333
New +$6.83K ﹤0.01% 448
2017
Q1 		– Sell
-448
Closed -$17K – 656
2016
Q4 		$17K Sell
448
-263
-37% -$10.5K ﹤0.01% 419
2016
Q3 		$33K Sell
711
-1,687
-70% -$88K ﹤0.01% 382
2016
Q2 		$121K Buy
2,398
+351
+17% +$18.7K 0.01% 275
2016
Q1 		$109K Sell
2,047
-297
-13% -$17.4K 0.01% 285
2015
Q4 		$156K Buy
+2,344
New +$145K 0.01% 251

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

Citizens Financial Group's TEVA Position: Q3 2019 in Review

Citizens Financial Group sold out of Teva Pharmaceuticals (TEVA) in Q3 2019, closing a stake of 900 shares — an estimated $8K sold.

Citizens Financial Group first reported a position in TEVA in Q4 2015 and held it in 7 quarters. The position peaked at $156K in Q4 2015. 427 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

  • Citizens Financial Group reported no remaining Teva Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Citizens Financial Group sold 900 Teva Pharmaceuticals shares in Q3 2019, an estimated $8K.
  • Citizens Financial Group first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 7 quarters.
  • Citizens Financial Group's Teva Pharmaceuticals position peaked at $156K in Q4 2015.
  • 427 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on Citizens Financial Group's 13F filing for Q3 2019, filed 1 Nov 2019.